SS
STLN

SBI Securities’s Starling Oncology STLN Stock Holding History

SBI Securities’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.69K Buy
+1,600
New +$6.72K ﹤0.01% 1910
2026
Q1 		– Sell
-3,500
Closed -$12.5K – 4154
2025
Q4 		$12.5K Hold
3,500
– – ﹤0.01% 1627
2025
Q3 		$12.2K Buy
3,500
+500
+17% +$1.71K ﹤0.01% 1679
2025
Q2 		$6.15K Buy
3,000
+2,800
+1,400% +$7K ﹤0.01% 1890
2025
Q1 		$228 Buy
+200
New +$155 ﹤0.01% 3177

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SBI Securities's STLN Position: Q2 2026 in Review

SBI Securities opened a new position in Starling Oncology (STLN) in Q2 2026: 1,600 shares worth $8.69K. The stake represents ﹤0.01% of the portfolio and ranks #1910 among its holdings. This is a return to the name: SBI Securities previously reported a position in STLN as recently as Q4 2025.

SBI Securities first reported a position in STLN in Q1 2025 and has held it in 5 quarters since. The position peaked at $12.5K in Q4 2025. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • SBI Securities held 1,600 shares of Starling Oncology worth $8.69K as of Q2 2026.
  • Starling Oncology was a new SBI Securities position in Q2 2026.
  • Starling Oncology made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1910 holding.
  • SBI Securities first reported a position in Starling Oncology in Q1 2025 and has held it in 5 quarters since.
  • SBI Securities's Starling Oncology position peaked at $12.5K in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.